Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
D000082:Acetaminophen / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D007114:Immunization / Q000009:adverse effects; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D008775:Methylprednisolone / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000276:immunology; D012129:Respiratory Function Tests; D012137:Respiratory System / Q000382:microbiology
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D004338:Drug Combinations; D000082:Acetaminophen; D008775:Methylprednisolone